ACAD ACADIA Pharmaceuticals Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 5, 2026
$19.95
· % 处于52周区间
· 高于低点
· 至高点
$19.5952周低点
$30.9652周高点
市值 (MRQ)
$3.43B
P/E (TTM)
8.9
EPS (TTM)
$2.23
收入 (TTM)
$1.14B
ACAD 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$19.95
市值 (MRQ)
$3.43B
P/E (TTM)
8.9
EPS (TTM)
$2.23
收入 (TTM)
$1.14B
ROE (TTM)
35.7%
52周区间
$20–$31
ACAD 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
关于 ACADIA Pharmaceuticals Inc. - Common Stock 公司概况（来自维基百科）
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Product development
Nuplazid, a drug developed by Acadia in the late 1990s, "was designed to stimulate a subset of the brain’s serotonin receptors, or the proteins that govern memory, cognition and learning." On April 29, 2016, the FDA approved Acadia's drug, Nuplazid, for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. Nuplazid is the trade name for Acadia's proprietary molecule, pimavanserin, a selective serotonin inverse agonist preferentially targeting 5-HT2a receptors. Acadia had partnered with Biovail in the late-stage clinical testing of the drug, which showed trial failures as of 2009.
Acadia is running multiple Phase 2 and Phase 3 trials with pimavanserin in several central nervous system conditions: dementia-related psychosis, major depressive disorder, schizophrenia inadequate response, and schizophrenia negative symptoms.
As of 1997, Acadia was among several companies that licensed compounds from Genzyme's small-molecule compound library.
In 2023, the FDA approved trofinetide (marketed as Daybue) for use in Rett syndrome.
History
Acadia started in 1993 as Receptor Technologies, based in Winooski, Vermont. In 1997, the company relocated all operations and management from Vermont to San Diego, California, as a strategic move to garner partnerships with other biotechnology companies. However, the company also had an office in Denmark, in which it received a crucial part of its early investments from BankInvest, under managing director Florian Schönharting, Kommunernes Pensionsforsikring A/S and Dansk Kapitalanlæg Aktieselskab as well as private investor Lars Christiansen. At the time, the company had fifty employees, fourteen of whom were in the Denmark office. The focus of the company in its early years was on genetic screens for receptors, aiming to accelerate early stage drug discovery.
The company planned to conduct an initial public offering (IPO) consisting of 31.6% of the company in 2001, with the intention of raising US$64 million and listing on the NASDAQ exchange under the symbol ACAD. At the time, Acadia and Allergan were collaborating on development of a treatment for glaucoma, and Allergan would retain a 6.3% ownership stake in Acadia after the IPO. However, the company's IPO, which ultimately took place in May 2004, did not fare as well as expected and netted only US$35 million. At the time, the company had five drugs in development and was running two in human trials. The company had a subsequent round of stock offering in May 2007 which raised US$102 million.
In September 2020, Acadia Pharmaceuticals acquired clinical-stage biotechnology company CerSci Therapeutics.
Corporate governance
In 2001, the company's chief executive officer at the time, Leonard R. Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016.
== References ==
来源：维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗
行业板块Healthcare
行业Biotechnology
员工796
国家US
10年表现 收入、净利润、利润率和每股收益趋势
收入$1.07B2016-12-31 → 2025-12-31
EPS$2.302020-12-31 → 2025-12-31
自由现金流$105M2016-12-31 → 2025-12-31
净利率33.4%2016-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | ACAD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 8.95年均值 ≈-18.7 | ≈-18.7 | 13.8 | 低估 | |
| P/S (TTM) | 3.05年均值 ≈5.5 | ≈5.5 | 11.9 | 低估 | |
| 市净率 (MRQ) | 2.65年均值 ≈6.6 | ≈6.6 | 3.4 | 低估 | |
| 股价/自由现金流 (TTM) | 23.65年均值 ≈64.0 | ≈64.0 | · | · | |
| 市现率 (TTM) | 21.45年均值 ≈63.4 | ≈63.4 | · | · | |
| 市净率（有形资产） (MRQ) | 2.95年均值 ≈7.3 | ≈7.3 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | ACAD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 7.6%5年均值 ≈-10.9% | ≈-10.9% | 12.5% | 持平 | |
| EBITDA Margin (息税折旧摊销前利润率) | 9.8%5年均值 ≈-10.9% | ≈-10.9% | 12.5% | 持平 | |
| 税前利润率 (TTM) | 10.7%5年均值 ≈-8.6% | ≈-8.6% | 16.4% | 持平 | |
| 净利润率 (TTM) | 33.4%5年均值 ≈-4.9% | ≈-4.9% | 10.2% | 持平 | |
| ROA (TTM) | 25.6%5年均值 ≈-2.7% | ≈-2.7% | -7.4% | 顶尖 | |
| ROE (TTM) | 35.7%5年均值 ≈-5.1% | ≈-5.1% | -10.7% | 顶尖 | |
| ROIC | 24.0%5年均值 ≈-11.4% | ≈-11.4% | -3.0% | 顶尖 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | ACAD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 3.45年均值 ≈3.8 | ≈3.8 | 6.5 | 低流动性 | |
| Quick Ratio (速动比率) | 1.15年均值 ≈1.4 | ≈1.4 | 5.0 | 低流动性 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | ACAD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 11.9%5年均值 ≈20.1% | ≈20.1% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 27.5%5年均值 ≈23.7% | ≈23.7% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 19.4% | · | · | · | |
| EPS YoY | 69.1% | · | · | · | |
| Net Income YoY (净利润同比增长) | 72.7% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | ACAD | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.85年均值 ≈0.9 | ≈0.9 | 0.4 | 顶尖 | |
| Inventory Turnover (库存周转率) | 0.95年均值 ≈1.1 | ≈1.1 | · | · | |
| Receivables Turnover (应收账款周转率) | 9.75年均值 ≈9.1 | ≈9.1 | 10.5 | 持平 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$1.3M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
228.8%
下次报告
十一月 03, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 11, 2026 | $0.18 | $0.06 | 207.2% |
| 2026年3月31日 | 五月 13, 2026 | $0.02 | $0.06 | -68.4% |
| 2025年12月31日 | $1.60 | $0.14 | 1044.5% | |
| 2025年9月30日 | $0.42 | $0.15 | 178.1% | |
| 2025年6月30日 | $0.16 | $0.14 | 14.4% | |
| 2025年3月31日 | $0.11 | $0.11 | -3.2% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Cost of Revenue | $89M | $82M | $42M | $10M | $19M | $10M | $11M | $12M | $9M | $3M | · | · | |
| Gross Profit | · | · | $685M | $507M | $473M | $432M | $328M | $211M | $116M | $14M | · | · | |
| R&D Expense | $329M | $303M | $352M | $362M | $239M | $319M | $240M | $187M | $149M | $99M | $74M | $61M | |
| SG&A Expense | $549M | $488M | $407M | $369M | $396M | $389M | $326M | $266M | $255M | $186M | $88M | $33M | |
| Operating Expenses | $967M | $727M | $800M | $741M | $655M | $728M | $586M | $471M | $417M | $290M | $165M | $93M | |
| Operating Income | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M | |
| Other Non-op | $2M | $2M | $5M | $4M | $2M | $-997.0K | $997.0K | $-2M | · | · | · | · | |
| Pretax Income | $139M | $258M | $-51M | $-213M | $-168M | $-281M | $-234M | $-244M | $-288M | $-270M | $-164M | $-92M | |
| Income Tax | $-252M | $32M | $10M | $3M | $351.0K | $611.0K | $876.0K | $1M | $1M | $1M | $330.0K | $0 | |
| Net Income | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| EPS (Basic) | $2.32 | $1.37 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| EPS (Diluted) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · | |
| Shares (Basic) | 168,356,000 | 165,717,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| Shares (Diluted) | 169,919,000 | 166,362,000 | 163,819,000 | 161,683,000 | 160,493 | 157,331 | · | · | · | · | · | · | |
| EBITDA | $105M | $231M | $-73M | $-224M | $-170M | $-287M | $-247M | $-247M | $-292M | $-273M | $-165M | $-93M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $178M | $320M | $189M | $115M | $147M | $326M | $190M | $135M | $69M | $164M | $102M | $62M | |
| Receivables | $121M | $99M | $98M | $62M | $64M | $48M | $36M | $26M | $17M | $6M | · | · | |
| Inventory | $111M | $92M | $40M | $12M | $14M | $10M | $6M | $4M | $5M | $4M | · | · | |
| Prepaid Expense | $60M | $56M | $39M | $21M | $24M | $26M | $19M | $21M | $8M | $8M | $2M | $1M | |
| Current Assets | $1.06B | $938M | $616M | $508M | $618M | $718M | $760M | $526M | $373M | $548M | $219M | $325M | |
| PP&E (Net) | $8M | $4M | $5M | $6M | $8M | $9M | $3M | $3M | $3M | $3M | $2M | $553.0K | |
| PP&E (Gross) | $17M | $14M | $14M | $14M | $14M | $13M | $9M | $8M | $7M | $6M | $5M | $3M | |
| Accum. Depreciation | $9M | $10M | $10M | $8M | $6M | $4M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Intangibles | $109M | $120M | $65M | $0 | $0 | $1M | $3M | $4M | $6M | $7M | · | · | |
| Other Non-current Assets | $4M | $359.0K | $476.0K | $8M | $4M | $2M | $3M | $2M | $354.0K | $785.0K | $329.0K | $287.0K | |
| Total Assets | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Accounts Payable | $11M | $16M | $18M | $13M | $7M | $8M | $7M | $3M | $9M | $4M | $2M | $2M | |
| Accrued Liabilities | $266M | $379M | $237M | $113M | $89M | $97M | $68M | $56M | $40M | $36M | $20M | $14M | |
| Current Liabilities | $277M | $395M | $254M | $126M | $96M | $106M | $75M | $60M | $49M | $43M | $22M | $16M | |
| Capital Leases | $41M | $42M | $48M | $53M | $56M | $44M | $6M | · | · | · | · | · | |
| Deferred Tax | $11M | $11M | $12M | $13M | $14M | $13M | $3M | · | · | · | · | · | |
| Other Non-current Liabilities | $19M | $18M | $15M | $9M | $7M | $5M | $3M | $2M | · | · | · | · | |
| Total Liabilities | $337M | $455M | $317M | $187M | $159M | $156M | $84M | $61M | $49M | $43M | $22M | $16M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $15.0K | $14.0K | $12.0K | $12.0K | $10.0K | $10.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | $1.45B | $862M | $808M | |
| Retained Earnings | $-1.81B | $-2.20B | $-2.43B | $-2.37B | $-2.15B | $-1.99B | $-1.70B | $-1.47B | $-1.22B | $-934M | $-663M | $-498M | |
| AOCI | $1M | $292.0K | $24.0K | $-975.0K | $-192.0K | $36.0K | $297.0K | $-372.0K | $-399.0K | $106.0K | $11.0K | $-9.0K | |
| Stockholders' Equity | $1.23B | $733M | $432M | $400M | $541M | $627M | $699M | $479M | $335M | $518M | $200M | $309M | |
| Liabilities + Equity | $1.56B | $1.19B | $749M | $588M | $700M | $783M | $783M | $540M | $385M | $561M | $222M | $325M | |
| Shares Outstanding | 170,309,376 | 166,708,856 | 164,650,219 | 162,064,872 | 161,012,695 | 159,637,771 | 155,275,300 | 143,853,597 | 124,410,552 | 121,367,169 | 101,938,702 | 100,047,331 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $206.0K | |
| Stock-based Comp | $52M | $67M | $66M | $68M | $64M | $84M | $82M | $82M | $76M | $55M | $40M | $16M | |
| Deferred Tax | $-250M | $0 | $0 | $3M | $351.0K | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $11M | $15M | $4M | $0 | $1M | $1M | $1M | $1M | $1M | $985.0K | $0 | $0 | |
| Operating Cash Flow | $110M | $158M | $17M | $-114M | $-126M | $-136M | $-151M | $-167M | $-218M | $-208M | $-122M | $-66M | |
| CapEx | $5M | $523.0K | $50.0K | $0 | $1M | $8M | $1M | $2M | $812.0K | $2M | $2M | $180.0K | |
| Investing Cash Flow | $-303M | $-31M | $32M | $73M | $-71M | $193M | $-166M | $-71M | $92M | $-262M | · | · | |
| Stock Issued | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Net Stock Activity | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $519M | $15M | $204M | |
| Financing Cash Flow | $50M | $7M | $25M | $8M | $18M | $81M | $372M | $307M | $31M | $534M | · | · | |
| Net Change in Cash | $-143M | $134M | $74M | $-33M | $-179M | $137M | $55M | $68M | $-94M | $63M | $40M | $50M | |
| Taxes Paid | $25M | $20M | $6M | $2M | $1M | $1M | $2M | $1M | $1M | $-365.0K | $415.0K | · | |
| Free Cash Flow | $105M | $157M | $17M | $-114M | $-127M | $-144M | $-152M | $-170M | $-219M | $-212M | $-124M | $-67M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 94.3% | 98.0% | 97.8% | 97.7% | 96.7% | 94.5% | 92.7% | 82.2% | · | · | |
| Operating Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| Net Margin | 36.5% | 23.6% | -8.4% | -41.8% | -34.7% | -63.7% | -69.4% | -109.6% | -231.7% | -1565.9% | -269578.7% | -77062.5% | |
| Pretax Margin | 13.0% | 26.9% | -7.0% | -41.3% | -34.6% | -63.6% | -69.1% | -109.0% | -230.8% | -1558.2% | -269037.7% | · | |
| EBITDA Margin | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% | -64.9% | -72.7% | -110.6% | -234.1% | -1574.1% | -269855.7% | -77691.7% | |
| ROA | 28.4% | 23.4% | -9.2% | -33.5% | -22.6% | -36.0% | -35.5% | -53.0% | -61.2% | -69.3% | -60.1% | -35.9% | |
| ROE | 38.1% | 34.6% | -15.4% | -52.3% | -30.3% | -43.9% | -33.9% | -69.8% | -67.8% | -75.6% | -64.6% | -37.6% | |
| ROIC | 24.0% | 27.6% | -20.4% | -56.5% | -31.6% | -45.8% | -35.4% | -51.9% | -87.5% | -52.9% | -82.6% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 | 6.8 | 10.2 | 8.8 | 7.6 | 12.9 | 10.0 | 20.5 | |
| Quick Ratio | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 | 3.5 | 3.0 | 2.7 | 1.8 | 4.0 | 4.7 | 3.9 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 1.0 | 1.1 | 0.8 | 0.7 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Inventory Turnover | 0.9 | 1.2 | 1.6 | 0.8 | 0.9 | 1.3 | 2.2 | · | 1.9 | 1.5 | · | · | |
| Receivables Turnover | 9.7 | 9.7 | 9.1 | 8.2 | 8.6 | 10.5 | 11.0 | 10.3 | 10.7 | 5.9 | · | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.21 | $4.40 | $2.62 | $2.47 | $3.36 | $3.93 | $4.50 | $3.33 | $2.69 | $4.27 | $1.96 | $3.09 | |
| Revenue / Share | $6.31 | $5.76 | $4434.39 | $3199.07 | · | · | · | · | · | · | · | · | |
| Cash Flow / Share | $0.65 | $0.95 | $101.95 | $-705.30 | · | · | · | · | · | · | · | · | |
| Cash / Share | $1.04 | $1.92 | $1.15 | $0.71 | $0.92 | $2.04 | $1.22 | $0.94 | $0.56 | $1.35 | $1.00 | $0.62 | |
| EPS (TTM) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 | $-1.79 | · | · | · | · | · | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.9% | 31.9% | 40.5% | 6.8% | 9.6% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 25.5% | 18.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.4% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 69.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 72.7% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.07B | $958M | $726M | $517M | $484M | $442M | $339M | $224M | $125M | $17M | $61.0K | $120.0K | |
| Net Income TTM | $391M | $226M | $-61M | $-216M | $-168M | $-282M | $-235M | $-245M | $-289M | $-271M | $-164M | $-92M | |
| Market Cap | $4.55B | $3.06B | $5.16B | $2.58B | $3.76B | $8.53B | $6.64B | $2.33B | $3.75B | $3.50B | $3.63B | $3.18B | |
| P/E | 11.6 | 13.5 | -84.6 | -11.9 | -22.2 | -29.9 | · | · | · | · | · | · | |
| P/S | 4.2 | 3.2 | 7.1 | 5.0 | 7.8 | 19.3 | 19.6 | 10.4 | 30.0 | 202.0 | 59575.7 | 26470.9 | |
| P/B | 3.7 | 4.2 | 11.9 | 6.4 | 6.9 | 13.6 | 9.5 | 4.9 | 11.2 | 6.8 | 18.2 | 10.3 | |
| P / Tangible Book | 4.1 | 5.0 | 14.1 | 6.4 | 6.9 | 13.6 | · | · | · | · | · | · | |
| P / Cash Flow | 41.4 | 19.4 | 308.7 | -22.6 | -29.9 | -62.7 | -44.0 | -13.9 | -17.2 | -16.6 | -29.8 | -47.8 | |
| P / FCF | 43.3 | 19.5 | 309.6 | -22.6 | -29.6 | -59.4 | -43.6 | -13.7 | -17.1 | -16.5 | -29.3 | -47.7 | |
| Earnings Yield | 8.6% | 7.4% | -1.2% | -8.4% | -4.5% | -3.4% | · | · | · | · | · | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $308M | $268M | $284M | $279M | $265M | $244M | $260M | $250M | $242M | $206M | $231M | $212M | $165M | $118M | $136M | $131M | |
| Cost of Revenue | $28M | $25M | $26M | $22M | $21M | $20M | $22M | $19M | $18M | $23M | $18M | $15M | $7M | $2M | $2M | $2M | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | $213M | $197M | $158M | $117M | $134M | $129M | |
| R&D Expense | $82M | $77M | $85M | $88M | $78M | $78M | $101M | $67M | $76M | $60M | $67M | $157M | $59M | $69M | $76M | $81M | |
| SG&A Expense | $160M | $171M | $156M | $133M | $134M | $126M | $130M | $133M | $117M | $108M | $111M | $98M | $96M | $101M | $104M | $78M | |
| Operating Expenses | $270M | $273M | $267M | $243M | $232M | $225M | $106M | $219M | $212M | $191M | $196M | $269M | $162M | $172M | $183M | $162M | |
| Operating Income | $38M | $-5M | $17M | $36M | $32M | $19M | $154M | $32M | $30M | $15M | $35M | $-58M | $3M | $-54M | $-46M | $-31M | |
| Other Non-op | $647.0K | $542.0K | $596.0K | $593.0K | $594.0K | $588.0K | $575.0K | $576.0K | $386.0K | $286.0K | $0 | $2M | $-1M | $5M | $2M | $2M | |
| Pretax Income | $46M | $4M | $26M | $45M | $40M | $28M | $161M | $39M | $37M | $21M | $40M | $-52M | $6M | $-45M | $-41M | $-26M | |
| Income Tax | $15M | $344.0K | $-247M | $-27M | $14M | $9M | $17M | $6M | $4M | $4M | $-6M | $13M | $5M | $-2M | $835.0K | $768.0K | |
| Net Income | $32M | $4M | $274M | $72M | $27M | $19M | $144M | $33M | $33M | $17M | $46M | $-65M | $1M | $-43M | $-42M | $-27M | |
| EPS (Basic) | $0.18 | $0.02 | $1.62 | $0.43 | $0.16 | $0.11 | $0.87 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| EPS (Diluted) | $0.18 | $0.02 | $1.61 | $0.42 | $0.16 | $0.11 | $0.86 | $0.20 | $0.20 | $0.10 | $0.29 | $-0.40 | $0.01 | $-0.27 | $-0.26 | $-0.17 | |
| Shares (Basic) | 171,603,000 | 170,517,000 | · | 168,836,000 | 167,827,000 | 166,808,000 | · | 165,974,000 | 165,551,000 | 164,798,000 | · | 164,234,000 | 163,458,000 | 162,263,000 | · | 161,852 | |
| Shares (Diluted) | 172,851,000 | 172,706,000 | · | 170,650,000 | 168,681,000 | 167,668,000 | · | 166,178,000 | 166,174,000 | 166,623,000 | · | 164,234,000 | 165,046,000 | 162,263,000 | · | 161,852 | |
| EBITDA | $38M | $-5M | · | $36M | $32M | $19M | · | $32M | $30M | $15M | · | $-58M | $3M | $-54M | · | $-31M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $385M | $282M | $178M | $258M | $254M | $218M | $320M | $155M | $177M | $205M | $189M | $98M | $108M | $291M | $115M | $155M | |
| Receivables | $151M | $135M | $121M | $116M | $108M | $106M | $99M | $98M | $104M | $95M | · | $93M | $82M | $66M | · | $56M | |
| Inventory | $109M | $112M | $111M | $106M | $111M | $103M | $92M | $87M | $86M | $67M | · | $25M | $14M | $11M | · | $12M | |
| Prepaid Expense | $69M | $65M | $60M | $61M | $53M | $53M | $56M | $52M | $46M | $43M | · | $38M | $24M | $24M | · | $23M | |
| Current Assets | $1.22B | $1.10B | $1.06B | $1.08B | $961M | $871M | $938M | $788M | $729M | $675M | · | $499M | $493M | $503M | · | $522M | |
| PP&E (Net) | $17M | $15M | $8M | $4M | $4M | $3M | $4M | $4M | $4M | $4M | · | $5M | $5M | $6M | · | $7M | |
| PP&E (Gross) | · | · | $17M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $9M | · | · | · | $10M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $103M | $106M | $109M | $112M | $114M | $117M | $120M | $106M | $108M | $110M | · | $67M | $68M | $70M | · | · | |
| Other Non-current Assets | $4M | $4M | $4M | $3M | $2M | $1M | $359.0K | $359.0K | $476.0K | $476.0K | · | $475.0K | $11M | $12M | · | $6M | |
| Total Assets | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Accounts Payable | $45M | $12M | $11M | $22M | $20M | $18M | $16M | $19M | $20M | $19M | · | $12M | $19M | $17M | · | $10M | |
| Accrued Liabilities | $317M | $293M | $266M | $335M | $310M | $284M | $379M | $325M | $318M | $311M | · | $197M | $169M | $207M | · | $107M | |
| Current Liabilities | $361M | $306M | $277M | $357M | $330M | $303M | $395M | $344M | $338M | $331M | · | $210M | $188M | $224M | · | $117M | |
| Capital Leases | $60M | $39M | $41M | $43M | $45M | $45M | $42M | $40M | $47M | $49M | · | $48M | $50M | $51M | · | $54M | |
| Deferred Tax | · | · | $11M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $15M | $13M | $19M | $14M | $29M | $20M | $18M | $15M | $12M | $11M | · | $13M | $9M | $5M | · | $6M | |
| Total Liabilities | $436M | $357M | $337M | $413M | $403M | $367M | $455M | $400M | $397M | $391M | · | $270M | $247M | $281M | · | $177M | |
| Common Stock | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | $16.0K | · | $16.0K | $16.0K | $16.0K | · | $16.0K | |
| Retained Earnings | $-1.78B | $-1.81B | $-1.81B | $-2.09B | $-2.16B | $-2.19B | $-2.20B | $-2.35B | $-2.38B | $-2.41B | · | $-2.48B | $-2.41B | $-2.41B | · | $-2.33B | |
| AOCI | $-958.0K | $-563.0K | $1M | $989.0K | $406.0K | $437.0K | $292.0K | $858.0K | $-339.0K | $-229.0K | · | $-319.0K | $-535.0K | $-220.0K | · | $-1M | |
| Stockholders' Equity | $1.31B | $1.25B | $1.23B | $917M | $822M | $765M | $733M | $577M | $517M | $464M | $432M | $362M | $396M | $374M | $400M | $426M | |
| Liabilities + Equity | $1.74B | $1.61B | $1.56B | $1.33B | $1.23B | $1.13B | $1.19B | $977M | $914M | $855M | · | $633M | $643M | $655M | · | $602M | |
| Shares Outstanding | 172,132,442 | 171,086,205 | 170,309,376 | 169,146,043 | 168,607,881 | 167,116,045 | 166,708,856 | 166,351,715 | 165,853,301 | 164,959,736 | · | 163,968,949 | 163,355,787 | 162,384,178 | · | 161,871,806 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $17M | $15M | $13M | $13M | $14M | $11M | $10M | $26M | $16M | $15M | $18M | $19M | $15M | $15M | $14M | $18M | |
| Amort. of Intangibles | $3M | $3M | $3M | $3M | $3M | $3M | $5M | $2M | $2M | $5M | $1M | $1M | $1M | $0 | $0 | $0 | |
| Operating Cash Flow | $101M | $34M | $-49M | $74M | $64M | $20M | $40M | $63M | $25M | $29M | $85M | $-59M | $8M | $-18M | $-24M | $-727.0K | |
| CapEx | $5M | $5M | $4M | $388.0K | $297.0K | $0 | $453.0K | $70.0K | · | · | $0 | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-9M | $66M | $-56M | $-79M | $-43M | $-124M | $122M | $-82M | $-56M | $-14M | $-347.0K | $34M | $-194M | $193M | $-18M | $15M | |
| Stock Issued | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Stock Activity | · | $4M | · | · | · | $2M | · | · | · | $1M | · | · | · | $1M | · | · | |
| Financing Cash Flow | $10M | $4M | $23M | $9M | $16M | $2M | $2M | $268.0K | $4M | $1M | $5M | $13M | $5M | $1M | $2M | $287.0K | |
| Net Change in Cash | $103M | $105M | $-82M | $4M | $37M | $-102M | $164M | $-19M | $-28M | $16M | $90M | $-12M | $-181M | $176M | $-40M | $15M | |
| Free Cash Flow | · | $29M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| Net Margin | 10.2% | 1.4% | · | 25.8% | 10.1% | 7.8% | · | 13.1% | 13.8% | 8.0% | · | -30.8% | 0.67% | -36.3% | · | -20.8% | |
| Pretax Margin | 15.1% | 1.5% | · | 16.0% | 15.2% | 11.4% | · | 15.5% | 15.4% | 10.2% | · | -24.6% | 3.8% | -37.9% | · | -20.2% | |
| EBITDA Margin | 12.3% | -1.7% | · | 12.8% | 12.2% | 7.9% | · | 12.6% | 12.6% | 7.4% | · | -27.3% | 1.8% | -45.2% | · | -23.6% | |
| ROA | 2.1% | 0.27% | · | 6.2% | 2.5% | 1.9% | · | 4.1% | 4.3% | 2.2% | · | -10.5% | 0.18% | -6.7% | · | -4.1% | |
| ROE | 3.0% | 0.36% | · | 9.6% | 4.0% | 3.1% | · | 7.0% | 7.3% | 4.0% | · | -16.6% | 0.27% | -10.5% | · | -5.5% | |
| ROIC | 2.0% | -0.34% | · | 6.3% | 2.6% | 1.7% | · | 4.6% | 5.3% | 2.6% | · | -19.9% | 0.13% | -13.7% | · | -7.5% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 3.6 | · | 3.0 | 2.9 | 2.9 | · | 2.3 | 2.2 | 2.0 | · | 2.4 | 2.6 | 2.2 | · | 4.5 | |
| Quick Ratio | 1.5 | 1.4 | · | 1.0 | 1.1 | 1.1 | · | 0.7 | 0.8 | 0.9 | · | 0.9 | 1.0 | 1.6 | · | 1.8 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.4 | 0.6 | · | 0.8 | 0.6 | 0.1 | · | 0.2 | |
| Receivables Turnover | 2.4 | 2.2 | · | 2.6 | 2.5 | 2.4 | · | 2.6 | 2.6 | 2.6 | · | 2.9 | 2.2 | 1.8 | · | 2.2 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.59 | $7.29 | · | $5.42 | $4.88 | $4.58 | · | $3.47 | $3.12 | $2.81 | · | $2.21 | $2.42 | $2.30 | · | $2.63 | |
| Revenue / Share | $1.78 | $1.55 | · | $1.63 | $1.57 | $1.46 | · | $1.51 | $1.46 | $1.24 | · | $1289.01 | $1001.15 | $0.73 | · | $807.61 | |
| Cash Flow / Share | · | $0.20 | · | · | · | $0.12 | · | · | · | $0.17 | · | · | · | $-0.11 | · | · | |
| Cash / Share | $2.24 | $1.65 | · | $1.53 | $1.50 | $1.30 | · | $0.93 | $1.07 | $1.24 | · | $0.60 | $0.66 | $1.79 | · | $0.96 | |
| EPS (TTM) | $2.23 | $2.21 | · | $1.55 | $1.33 | $1.37 | · | $0.79 | $0.19 | $0.00 | · | $-0.92 | $-0.69 | $-0.91 | · | $-1.35 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.14B | $1.10B | · | $1.05B | $1.02B | $996M | · | $929M | $891M | $814M | · | $632M | $551M | $520M | · | $512M | |
| Net Income TTM | $380M | $376M | · | $261M | $222M | $229M | · | $129M | $31M | $-2M | · | $-149M | $-111M | $-146M | · | $-217M | |
| Market Cap | $4.35B | $3.81B | · | $3.61B | $3.64B | $2.78B | · | $2.56B | $2.70B | $3.05B | · | $3.42B | $3.91B | $3.06B | · | $2.65B | |
| P/E | 11.3 | 10.1 | · | 13.8 | 16.2 | 12.1 | · | 19.5 | 85.5 | · | · | -22.7 | -34.7 | -20.7 | · | -12.1 | |
| P/S | 3.8 | 3.5 | · | 3.4 | 3.6 | 2.8 | · | 2.8 | 3.0 | 3.7 | · | 5.4 | 7.1 | 5.9 | · | 5.2 | |
| P/B | 3.3 | 3.1 | · | 3.9 | 4.4 | 3.6 | · | 4.4 | 5.2 | 6.6 | · | 9.4 | 9.9 | 8.2 | · | 6.2 | |
| P / Tangible Book | 3.6 | 3.3 | · | 4.5 | 5.1 | 4.3 | · | 5.4 | 6.6 | 8.6 | · | 11.6 | 11.9 | 10.0 | · | 6.2 | |
| P / Cash Flow | · | 112.1 | · | · | · | 136.6 | · | · | · | 104.9 | · | · | · | -170.4 | · | · | |
| Earnings Yield | 8.8% | 9.9% | · | 7.3% | 6.2% | 8.2% | · | 5.1% | 1.2% | 0.00% | · | -4.4% | -2.9% | -4.8% | · | -8.2% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $1.07B | $958M | $726M | $517M | $484M |
| 毛利率 % | · | · | 94.3% | 98.0% | 97.8% |
| 营业利润率 % | 9.8% | 24.1% | -10.1% | -43.2% | -35.2% |
| 净收入 | $391M | $226M | $-61M | $-216M | $-168M |
| 稀释后每股收益 (EPS) | $2.30 | $1.36 | $-0.37 | $-1.34 | $-1.05 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 3.8 | 2.4 | 2.4 | 4.0 | 6.4 |
| 速动比率 | 1.1 | 1.1 | 1.1 | 1.4 | 2.2 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $105M | $157M | $17M | $-114M | $-127M |
机构持有人 (13F) 385 家申报者 · $4.7B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
385
持有价值
$4.7B
新仓位
49
已退出持仓
36
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 49 (-4 与上一季度对比) | 36 (+8 与上一季度对比) | 135 (+15 与上一季度对比) | 115 (-7 与上一季度对比) | +4.6M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $1085696471 | 42912904 | 23.31% | 股份 |
| BlackRock, Inc. | $569633876 | 22515173 | 12.23% | 股份 |
| VANGUARD GROUP INC | $404762192 | 15153957 | 8.69% | 股份 |
| STATE STREET CORP | $229628164 | 9076212 | 4.93% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $223612785 | 8838450 | 4.80% | 股份 |
| RTW INVESTMENTS, LP | $180756457 | 7144524 | 3.88% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $145822875 | 5763750 | 3.13% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $93482749 | 3694988 | 2.01% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $84977229 | 3358129 | 1.82% | 股份 |
| Palo Alto Investors LP | $72461629 | 2864096 | 1.56% | 股份 |
| GOLDMAN SACHS GROUP INC | $65276910 | 2580115 | 1.40% | 股份 |
| Qube Research & Technologies Ltd | $61899233 | 2446610 | 1.33% | 股份 |
| Point72 Asset Management, L.P. | $61559150 | 2433168 | 1.32% | 股份 |
| CITADEL ADVISORS LLC | $55209078 | 2182177 | 1.19% | 股份 |
| Pictet Asset Management Holding SA | $50146450 | 1983198 | 1.08% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $49826959 | 1969445 | 1.07% | 股份 |
| MARSHALL WACE, LLP | $44650402 | 1764838 | 0.96% | 股份 |
| D. E. Shaw & Co., Inc. | $42957806 | 1697937 | 0.92% | 股份 |
| BRAIDWELL LP | $41653895 | 1646399 | 0.89% | 股份 |
| NORGES BANK | $41069692 | 1623308 | 0.88% | 股份 |
| Frazier Life Sciences Management, L.P. | $36386409 | 1438198 | 0.78% | 股份 |
| NORTHERN TRUST CORP | $34595776 | 1367422 | 0.74% | 股份 |
| Nuveen, LLC | $34109259 | 1348192 | 0.73% | 股份 |
| Artisan Partners Limited Partnership | $33525890 | 1325134 | 0.72% | 股份 |
| BANK OF AMERICA CORP /DE/ | $32899740 | 1300385 | 0.71% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $32449679 | 1282596 | 0.70% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $30520301 | 1206336 | 0.66% | 股份 |
| Allspring Global Investments Holdings, LLC | $28540663 | 1132566 | 0.61% | 股份 |
| Rockefeller Capital Management L.P. | $25690127 | 1015420 | 0.55% | 股份 |
| MORGAN STANLEY | $23949976 | 946639 | 0.51% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $23452898 | 926992 | 0.50% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $23082961 | 912370 | 0.50% | 股份 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $21642506 | 855435 | 0.46% | 股份 |
| Invesco Ltd. | $20504689 | 810462 | 0.44% | 股份 |
| PRINCIPAL FINANCIAL GROUP INC | $19966658 | 789196 | 0.43% | 股份 |
| Bank of New York Mellon Corp | $19243919 | 760629 | 0.41% | 股份 |
| Allianz Asset Management GmbH | $19157034 | 757195 | 0.41% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $17985922 | 710906 | 0.39% | 股份 |
| Fisher Asset Management, LLC | $17690535 | 699230 | 0.38% | 股份 |
| FRED ALGER MANAGEMENT, LLC | $16409858 | 648611 | 0.35% | 股份 |
| RICE HALL JAMES & ASSOCIATES, LLC | $15657841 | 618887 | 0.34% | 股份 |
| AMERIPRISE FINANCIAL INC | $15348144 | 606536 | 0.33% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $14925077 | 589924 | 0.32% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $14771456 | 583852 | 0.32% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $13225551 | 522749 | 0.28% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12903000 | 510000 | 0.28% | 股份 |
| GLENMEDE TRUST CO NA | $12360212 | 488546 | 0.27% | 股份 |
| Hudson Bay Capital Management LP | $11764500 | 465000 | 0.25% | 股份 |
| UBS Group AG | $11639341 | 460053 | 0.25% | 股份 |
| JUPITER ASSET MANAGEMENT LTD | $11599190 | 458466 | 0.25% | 股份 |
激进投资者及 5%+ 股东 6 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×14 申报 | 2026年2月26日 | 25.40% | 修订 | · | SEC |
| Baker Bros. Advisors, LLC, Felix J. Baker, Julian C. Baker ×4 申报 | 2013年6月6日 | · | 初始申报 | · | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2005年5月2日 | · | 初始申报 | · | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2005年5月2日 | · | 初始申报 | · | SEC |
| 未披露的报告人, 未披露的报告人, 未披露的报告人 | 2005年5月2日 | · | 初始申报 | · | SEC |
| Oxford Bioscience Partners IV L.P., mRNA Fund II L.P., OBP Management IV L.P., Jeffrey T. Barnes, Mark P. Carthy, Jonathan J. Fleming, Michael E. Lytton, Alan G. Walton | 2005年4月29日 | · | 初始申报 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 42 位内幕人士 · 24 位高管 · 21 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Adams Catherine Owen | Chief Executive Officer | 2026年3月24日 M | 14803 | 0 | 1 | $-249932 |
| Stephen Davis | CEO | 2024年8月19日 S | 186555 | 0 | 0 | $0 |
| Uli Hacksell | CEO | 2015年2月17日 M | 115549 | 0 | 0 | $0 |
| Mark C. Schneyer | EVP, CHIEF FINANCIAL OFFICER | 2026年8月6日 M | 67828 | 0 | 9 | $-1126027 |
| Elena Ridloff | EVP and CFO | 2021年4月29日 M | 10553 | 0 | 0 | $0 |
| Todd S. Young | EVP AND CFO | 2018年10月15日 A | · | 0 | 0 | $0 |
| Thomas H Aasen | EXEC VP, CFO AND CBO | 2014年4月4日 M | 0 | 0 | 0 | $0 |
| Srdjan R. Stankovic | President | 2022年11月21日 M | 61234 | 0 | 0 | $0 |
| Mark R Brann | President & CSO | 2006年6月16日 S | 317756 | 0 | 0 | $0 |
| Brendan Teehan | EVP, COO, HEAD OF COMMERCIAL | 2024年11月17日 M | 62105 | 0 | 0 | $0 |
| Elizabeth H.Z. Thompson | EVP, Head of Research & Dev | 2026年7月29日 M | 18994 | 0 | 3 | $-506411 |
| James Kihara | PRINCIPAL ACCOUNTING OFFICER | 2026年6月26日 S | 13088 | 0 | 8 | $-602789 |
| Jennifer J Rhodes | EVP, CHIEF LEGAL OFFICER, SEC | 2026年3月24日 M | 11280 | 0 | 2 | $-245022 |
| Thomas Garner | EVP, Chief Commercial Officer | 2026年3月6日 A | · | 0 | 0 | $0 |
| Austin D. Kim | EVP,General Counsel, Secretary | 2024年1月6日 M | 46901 | 0 | 0 | $0 |
| Douglas J Williamson | Executive VP, Research & Dev | 2023年2月10日 A | · | 0 | 0 | $0 |
| Michael J. Yang | EVP and CCO | 2021年1月6日 M | 8059 | 0 | 0 | $0 |
| Eric Alejandro Miller | Controller & PAO | 2019年10月15日 M | 270 | 0 | 0 | $0 |
| Glenn Baity | EVP AND GC | 2018年4月18日 A | 83734 | 0 | 0 | $0 |
| Terrence O Moore | EVP, CHIEF COMMERCIAL OFFICER | 2017年3月8日 A | 1671 | 0 | 0 | $0 |
| Roger Mills | EVP, DEVELOPMENT AND CMO | 2015年3月20日 A | 18550 | 0 | 0 | $0 |
| Bo-Ragnar Tolf | VP/Mg. Dir. ACADIA Pharma AB | 2009年7月8日 M | 20000 | 0 | 0 | $0 |
| Brian Lundstrom | Sr. VP, Bus. Development | 2008年3月7日 A | 0 | 0 | 0 | $0 |
| Robert E Davis | Exec. VP, Drug Discovery | 2005年3月11日 A | · | 0 | 0 | $0 |
| Adora Ndu | 董事 | 2026年5月29日 A | 32908 | 0 | 0 | $0 |
| Elizabeth A. Garofalo | 董事 | 2026年5月29日 A | 33489 | 0 | 0 | $0 |
| Jonathan Poole | 董事 | 2026年5月29日 A | 2010 | 0 | 0 | $0 |
| James M Daly | 董事 | 2026年5月29日 A | 12148 | 0 | 1 | $-671100 |
| Laura Brege | 董事 | 2026年5月29日 A | 23202 | 0 | 0 | $0 |
| Edmund Harrigan | 董事 | 2026年5月29日 A | 43148 | 0 | 0 | $0 |
| Daniel B Soland | 董事 | 2025年5月29日 A | 44041 | 0 | 0 | $0 |
| Mary Ann Gray | 董事 | 2016年6月7日 M | 149476 | 0 | 0 | $0 |
| Leslie L Iversen | 董事 | 2016年4月18日 M | 36127 | 0 | 0 | $0 |
| Lester J Ph D Kaplan | 董事 | 2015年8月11日 M | 17000 | 0 | 0 | $0 |
| William Mcdowall Wells | 董事 | 2015年6月15日 A | 0 | 0 | 0 | $0 |
| Torsten Rasmussen | 董事 | 2015年6月15日 A | 8500 | 0 | 0 | $0 |
| Michael T Borer | 董事 | 2015年6月15日 A | 0 | 0 | 0 | $0 |
| Gordon M Binder | 董事 | 2009年6月12日 A | 14364 | 0 | 0 | $0 |
| Alan G Walton | 董事 | 2009年6月12日 A | 25979 | 0 | 0 | $0 |
| Martien Van Osch | 董事 | 2005年6月10日 A | 1168892 | 0 | 0 | $0 |
| GORDON CARL L | 董事 | 2005年4月20日 A | 774006 | 0 | 0 | $0 |
| John Joseph Kaiser | · | 2008年10月20日 A | · | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 59 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IBRN · iShares Trust | 4.92% | 13265 SH | 2026年9月11日 | 每日 |
| PBE · Invesco Exchange-Traded Fund Trust | 1.82% | 383853 SH | 2026年10月1日 | 每日 |
| BBP · ETFis Series Trust I | 1.69% | 64350 NS | 2026年7月31日 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trus... | 1.40% | 124236 SH | 2026年10月1日 | 每日 |
| RZG · Invesco Exchange-Traded Fund Trust | 0.97% | 57480 SH | 2026年10月1日 | 每日 |
| LABU · Direxion Shares ETF Trust | 0.71% | 134777 NS | 2026年7月31日 | N-PORT |
| ROSC · Lattice Strategies Trust | 0.62% | 14725 NS | 2026年7月31日 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0.35% | 150827 SH | 2026年8月19日 | 每日 |
| IBB · iShares Trust | 0.35% | 1293913 SH | 2026年9月11日 | 每日 |
| IWO · iShares Trust | 0.24% | 1215092 SH | 2026年9月11日 | 每日 |
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.23% | 12181 SH | 2026年10月1日 | 每日 |
| PWS · Pacer Funds Trust | 0.20% | 1841 NS | 2026年7月31日 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.19% | 137860 SH | 2026年8月19日 | 每日 |
| BKSE · BNY Mellon ETF Trust | 0.19% | 6256 NS | 2026年7月31日 | N-PORT |
| QVMS · Invesco Exchange-Traded Fund Trus... | 0.17% | 19976 SH | 2026年10月1日 | 每日 |
| VIOO · VANGUARD ADMIRAL FUNDS | 0.17% | 443221 SH | 2026年8月19日 | 每日 |
| FNY · First Trust Exchange-Traded Alpha... | 0.16% | 36279 NS | 2026年7月31日 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund ... | 0.13% | 34493 NS | 2026年7月31日 | N-PORT |
| IWM · iShares Trust | 0.12% | 3296450 SH | 2026年9月11日 | 每日 |
| ISCG · iShares Trust | 0.12% | 40348 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.11% | 140676 SH | 2026年10月1日 | 每日 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.10% | 741237 SH | 2026年8月19日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.09% | 559090 NS | 2026年7月31日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.09% | 1699377 SH | 2026年8月19日 | 每日 |
| FNX · First Trust Exchange-Traded Alpha... | 0.08% | 40712 NS | 2026年7月31日 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trus... | 0.05% | 52423 SH | 2026年10月1日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.05% | 10893 NS | 2026年7月31日 | N-PORT |
| SMDX · Tidal Trust III | 0.05% | 2295 NS | 2026年7月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 54681 NS | 2026年7月31日 | N-PORT |
| IEUS · iShares Trust | 0.04% | 7263 SH | 2026年9月11日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.04% | 1457036 SH | 2026年8月19日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.04% | 2944095 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.04% | 346329 SH | 2026年8月19日 | 每日 |
| PDN · Invesco Exchange-Traded Fund Trus... | 0.04% | 13154 SH | 2026年10月1日 | 每日 |
| WSML · iShares Trust | 0.04% | 11751 SH | 2026年9月11日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.03% | 4009 SH | 2026年10月1日 | 每日 |
| DXUV · Dimensional ETF Trust | 0.02% | 5018 NS | 2026年7月31日 | N-PORT |
| ISCF · iShares Trust | 0.02% | 13099 SH | 2026年9月11日 | 每日 |
| DFUV · Dimensional ETF Trust | 0.02% | 113182 NS | 2026年7月31日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.02% | 348929 NS | 2026年7月31日 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.02% | 103974 NS | 2026年7月31日 | N-PORT |
| SCZ · iShares Trust | 0.02% | 238968 SH | 2026年9月9日 | 每日 |
| DCOR · Dimensional ETF Trust | 0.01% | 16150 NS | 2026年7月31日 | N-PORT |
| ESGV · VANGUARD WORLD FUND | 0.01% | 28150 SH | 2026年8月19日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.01% | 39121 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 35516 SH | 2026年9月10日 | 每日 |
| ITOT · iShares Trust | 0.00% | 161527 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 35634 NS | 2026年7月31日 | N-PORT |
| IEFA · iShares Trust | 0.00% | 240578 SH | 2026年9月11日 | 每日 |
| TILT · FlexShares Trust | 0.00% | 632 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4075731 SH | 2026年8月19日 | 每日 |
| VT · VANGUARD INTERNATIONAL EQUITY IND... | 0.00% | 100076 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10781 SH | 2026年8月19日 | 每日 |
| IJR · iShares Trust | · | 7728763 SH | 2026年9月10日 | 每日 |
| IJT · iShares Trust | · | 1198794 SH | 2026年9月9日 | 每日 |
| XJR · iShares Trust | · | 17544 SH | 2026年8月31日 | 每日 |
| ISCB · iShares Trust | · | 5636 SH | 2026年9月11日 | 每日 |
| SMLF · iShares Trust | · | 221806 SH | 2026年9月11日 | 每日 |
| SMMV · iShares Trust | · | 16924 SH | 2026年8月19日 | 每日 |
ACAD 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 27 位分析师
买入
中位数目标
$33.00
+65.4%
7 25.9%
强烈买入
14 51.9%
买入
5 18.5%
持有
1 3.7%
卖出
0 0.0%
强烈卖出
12个月价格目标
19 位分析师 · 2026-09-29平均目标 $32.16 +61.2%
现在
当前价格 $19.95
最低$17.00
平均值$32.16
最高$49.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
最新新闻 提及该公司的近期头条新闻
交易信号 近期买入/卖出信号，包含入场价和风险/回报比
BLUECHIP_DIP
已过期
风险 1
奖励 5.00
入场
$21.20
R:R 5.00
BLUECHIP_DIP
止损出局
风险 1
奖励 4.79
入场
$21.86
R:R 4.79
BLUECHIP_DIP
止损出局
风险 1
奖励 4.99
入场
$22.45
R:R 4.99
目前没有公开信号 — 没有卡片被填写，这是诚实的。
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 5, 2026 申报